BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34795299)

  • 1. Mechanistic principles of an ultra-long bovine CDR reveal strategies for antibody design.
    Svilenov HL; Sacherl J; Protzer U; Zacharias M; Buchner J
    Nat Commun; 2021 Nov; 12(1):6737. PubMed ID: 34795299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Unusual Genetics and Biochemistry of Bovine Immunoglobulins.
    Stanfield RL; Haakenson J; Deiss TC; Criscitiello MF; Wilson IA; Smider VV
    Adv Immunol; 2018; 137():135-164. PubMed ID: 29455846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles of antibodies with ultralong complementarity-determining regions and picobodies.
    Passon M; De Smedt S; Svilenov HL
    Biotechnol Adv; 2023; 64():108120. PubMed ID: 36764335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific features of a scaffolding antibody light chain.
    Trommer J; Lesniowski F; Buchner J; Svilenov HL
    Protein Sci; 2024 May; 33(5):e4990. PubMed ID: 38607241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing Antibody Affinity and Developability Using a Framework-CDR Shuffling Approach-Application to an Anti-SARS-CoV-2 Antibody.
    Gopal R; Fitzpatrick E; Pentakota N; Jayaraman A; Tharakaraman K; Capila I
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2.
    Huang R; Warner Jenkins G; Kim Y; Stanfield RL; Singh A; Martinez-Yamout M; Kroon GJ; Torres JL; Jackson AM; Kelley A; Shaabani N; Zeng B; Bacica M; Chen W; Warner C; Radoicic J; Joh J; Dinali Perera K; Sang H; Kim T; Yao J; Zhao F; Sok D; Burton DR; Allen J; Harriman W; Mwangi W; Chung D; Teijaro JR; Ward AB; Dyson HJ; Wright PE; Wilson IA; Chang KO; McGregor D; Smider VV
    Proc Natl Acad Sci U S A; 2023 Sep; 120(39):e2303455120. PubMed ID: 37722054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody.
    Kim SI; Kim S; Kim J; Chang SY; Shim JM; Jin J; Lim C; Baek S; Min JY; Park WB; Oh MD; Kim S; Chung J
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational design of protein antigens that interact with the CDR H3 loop of HIV broadly neutralizing antibody 2F5.
    Azoitei ML; Ban YA; Kalyuzhny O; Guenaga J; Schroeter A; Porter J; Wyatt R; Schief WR
    Proteins; 2014 Oct; 82(10):2770-82. PubMed ID: 25043744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline-Encoded Positional Cysteine Polymorphisms Enhance Diversity in Antibody Ultralong CDR H3 Regions.
    Jenkins GW; Safonova Y; Smider VV
    J Immunol; 2022 Dec; 209(11):2141-2148. PubMed ID: 36426974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity in the Cow Ultralong CDR H3 Antibody Repertoire.
    Haakenson JK; Huang R; Smider VV
    Front Immunol; 2018; 9():1262. PubMed ID: 29915599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of single-chain Fv with two possible CDR3H conformations but similar inter-molecular forces that neutralize bovine herpesvirus 1.
    Koti M; Farrugia W; Nagy E; Ramsland PA; Kaushik AK
    Mol Immunol; 2010 Feb; 47(5):953-60. PubMed ID: 20006385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proximity of the N- and C- termini of bovine knob domains enable engineering of target specificity into polypeptide chains.
    Hawkins A; Joyce C; Brady K; Hold A; Smith A; Knight M; Howard C; van den Elsen J; Lawson ADG; Macpherson A
    MAbs; 2022; 14(1):2076295. PubMed ID: 35634719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RosettaAntibodyDesign (RAbD): A general framework for computational antibody design.
    Adolf-Bryfogle J; Kalyuzhniy O; Kubitz M; Weitzner BD; Hu X; Adachi Y; Schief WR; Dunbrack RL
    PLoS Comput Biol; 2018 Apr; 14(4):e1006112. PubMed ID: 29702641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservation and diversity in the ultralong third heavy-chain complementarity-determining region of bovine antibodies.
    Stanfield RL; Wilson IA; Smider VV
    Sci Immunol; 2016 Jul; 1(1):. PubMed ID: 27574710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs.
    Tiller KE; Li L; Kumar S; Julian MC; Garde S; Tessier PM
    J Biol Chem; 2017 Oct; 292(40):16638-16652. PubMed ID: 28778924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide.
    Entzminger KC; Hyun JM; Pantazes RJ; Patterson-Orazem AC; Qerqez AN; Frye ZP; Hughes RA; Ellington AD; Lieberman RL; Maranas CD; Maynard JA
    Sci Rep; 2017 Aug; 7(1):10295. PubMed ID: 28860479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diversity of H3 loops determines the antigen-binding tendencies of antibody CDR loops.
    Tsuchiya Y; Mizuguchi K
    Protein Sci; 2016 Apr; 25(4):815-25. PubMed ID: 26749247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of domain antibodies reveals aggregation hotspots within and near the complementarity determining regions.
    Perchiacca JM; Bhattacharya M; Tessier PM
    Proteins; 2011 Sep; 79(9):2637-47. PubMed ID: 21732420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of antigen-specific, disulphide-rich knob domain peptides from bovine antibodies.
    Macpherson A; Scott-Tucker A; Spiliotopoulos A; Simpson C; Staniforth J; Hold A; Snowden J; Manning L; van den Elsen J; Lawson ADG
    PLoS Biol; 2020 Sep; 18(9):e3000821. PubMed ID: 32886672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.